Isabel Struik has been appointed head of business development in Europe for ACM Global Central Lab. Ms. Struik joins the executive management team and will be responsible for business development efforts throughout the region. She has extensive experience in clinical research having worked in the industry for more than 13 years, in all major therapeutic areas.
Prior to joining the company, she was director of business development at Cromsource, an international provider of clinical development services, where she was head of business development. Prior to that, she was associate director, business development for PharmaNet, where she was responsible for establishing a generics and biosimilars product portfolio for late stage studies. Ms. Struik also spent several years at Kendle International, where she served in roles of increasing strategic responsibility, including business development and support manager.
“Isabel has extensive business development experience in the clinical trials industry and a thorough understanding of the logistics and challenges involved when it comes to central lab activities in clinical research,” said Angela J. Panzarella, president of ACM Global Central Lab. “We are thrilled to welcome her to our team.”